4//SEC Filing
Innovive Pharmaceuticals, Inc. 4
Accession 0001181431-07-045403
CIK 0001337223operating
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:46 PM ET
Size
9.5 KB
Accession
0001181431-07-045403
Insider Transaction Report
Form 4
Poma Eric E
VP - Business Development
Transactions
- Award
Stock Option (Right to Buy)
2007-07-10+37,500→ 37,500 totalExercise: $4.00Exp: 2017-07-10→ Common Stock (37,500 underlying) - Award
Stock Option (Right to Buy
2007-07-10+37,500→ 37,500 totalExercise: $5.00Exp: 2017-07-10→ Common Stock (37,500 underlying)
Holdings
- 63,160
Common Stock
- 60,000
Stock Option (Right to Buy)
Exercise: $3.96Exp: 2016-08-08→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Option vests in three equal annual installments beginning on August 8, 2007.
- [F2]Option vests in three equal annual installments beginning on July 10, 2008.
Documents
Issuer
Innovive Pharmaceuticals, Inc.
CIK 0001337223
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001337223
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:46 PM ET
- Size
- 9.5 KB